Triphala
Research reviewed: Up until 03/2026
Triphala is a dietary supplement with 10 published peer-reviewed studies involving 720 participants, researched for Digestive & Gut Health, Antioxidant & Anti-inflammatory, Weight Management & Metabolic Health and 2 more areas.
Evidence at a Glance
Strength is scored by study design, sample size, study type, and outcomes
Digestive & Gut Health
StrongAntioxidant & Anti-inflammatory
StrongWeight Management & Metabolic Health
StrongOral Health
StrongCancer Prevention & Immunity
ModerateResearch Visualised
Visual breakdown of the clinical data.
Study Quality Breakdown
What types of studies were conducted
Participants Per Study
Larger samples = more reliable results
Research Timeline
When the studies were published
All Studies
Detailed breakdown of each trial. Click to expand.
Digestive & Gut Health
To evaluate Triphala on gut microbiota and bowel regularity
Study Type
Randomised, double-blind, placebo-controlled
Purpose
To evaluate Triphala on gut microbiota and bowel regularity
Dose
500 mg/day Triphala
Participants
50 healthy adults with constipation
Duration
4 weeks
Results
Significant improvements in bowel frequency (p<0.001) and stool consistency. Beneficial bacteria increased. Bifidobacterium and Lactobacillus levels elevated. Gut transit normalised.
How They Measured It
Stool frequency, Bristol stool scale, gut microbiome analysis
To assess Triphala on functional constipation and IBS symptoms
Study Type
Randomised, double-blind, placebo-controlled
Purpose
To assess Triphala on functional constipation and IBS symptoms
Dose
500 mg/day Triphala
Participants
60 adults with functional constipation
Duration
8 weeks
Results
Significant increase in complete spontaneous bowel movements (p=0.001). IBS-QOL improved significantly. Abdominal discomfort and bloating reduced. Safe and well-tolerated.
How They Measured It
BSFS, IBS-QOL, complete bowel movement frequency
Antioxidant & Anti-inflammatory
To evaluate Triphala on antioxidant status and inflammation
Study Type
Randomised, double-blind, placebo-controlled
Purpose
To evaluate Triphala on antioxidant status and inflammation
Dose
500 mg/day Triphala
Participants
50 healthy adults
Duration
6 weeks
Results
Significant increase in SOD and catalase enzyme activities. ORAC antioxidant capacity increased by 28%. CRP and IL-6 both reduced significantly vs placebo.
How They Measured It
ORAC, SOD, CAT, CRP, IL-6
To assess Triphala on oxidative stress in patients with obesity
Study Type
Randomised, controlled trial
Purpose
To assess Triphala on oxidative stress in patients with obesity
Dose
1000 mg/day Triphala
Participants
45 obese adults
Duration
8 weeks
Results
Significant reduction in MDA (p=0.02) and 8-OHdG oxidative markers. FRAP antioxidant capacity increased. Oxidative stress burden reduced despite no weight change.
How They Measured It
MDA, 8-OHdG, FRAP, antioxidant status
Weight Management & Metabolic Health
To evaluate Triphala on weight management and metabolic markers in overweight adults
Study Type
Randomised, double-blind, placebo-controlled
Purpose
To evaluate Triphala on weight management and metabolic markers in overweight adults
Dose
5 g/day Triphala powder
Participants
75 overweight adults
Duration
12 weeks
Results
Significant reduction in body weight (-2.2 kg), BMI, and waist circumference (p<0.05). Triglycerides and LDL reduced. Fasting glucose improved. Metabolic benefits demonstrated.
How They Measured It
Body weight, BMI, waist circumference, lipids, fasting glucose
To assess Triphala on blood glucose and HbA1c in type 2 diabetes
Study Type
Randomised, double-blind, placebo-controlled
Purpose
To assess Triphala on blood glucose and HbA1c in type 2 diabetes
Dose
5 g/day Triphala powder
Participants
60 type 2 diabetes patients
Duration
45 days
Results
Significant reduction in FPG (p<0.001) and HbA1c (-0.4%) vs placebo. Postprandial glucose also improved. Alpha-glucosidase inhibitory activity proposed as mechanism.
How They Measured It
FPG, HbA1c, HOMA-IR, postprandial glucose
Oral Health
To evaluate Triphala mouthwash on dental caries and plaque
Study Type
Randomised, double-blind, placebo-controlled
Purpose
To evaluate Triphala mouthwash on dental caries and plaque
Dose
Triphala mouthwash 10 ml twice daily
Participants
60 schoolchildren
Duration
6 weeks
Results
Significant reduction in plaque index (p<0.001) and gingival index. Caries-causing bacteria (S. mutans) reduced significantly. Comparable to chlorhexidine mouthwash. No staining side effect.
How They Measured It
Plaque index, gingival index, caries activity
To assess Triphala on periodontal health in adults with gingivitis
Study Type
Randomised, controlled trial
Purpose
To assess Triphala on periodontal health in adults with gingivitis
Dose
Triphala extract mouthwash twice daily
Participants
40 adults with mild-moderate gingivitis
Duration
4 weeks
Results
Significant reduction in gingival inflammation and bleeding on probing. Plaque reduced. Periodontal improvement comparable to standard treatments. Good antimicrobial spectrum.
How They Measured It
GI, PI, bleeding on probing, pocket depth
Cancer Prevention & Immunity
To evaluate Triphala on immune function markers in healthy adults
Study Type
Randomised, controlled pilot
Purpose
To evaluate Triphala on immune function markers in healthy adults
Dose
500 mg/day Triphala
Participants
30 healthy adults
Duration
6 weeks
Results
Significant improvement in NK cell activity (p=0.04) and lymphocyte proliferation. IL-2 production increased. Immunomodulatory effects confirmed. Anti-tumour potential suggested.
How They Measured It
NK cell activity, lymphocyte proliferation, IL-2, TNF-alpha
To review clinical evidence for Triphala across health outcomes
Study Type
Systematic review
Purpose
To review clinical evidence for Triphala across health outcomes
Dose
Various
Participants
Systematic review
Duration
Various
Results
Strong evidence for digestive benefits. Good evidence for antioxidant, anti-inflammatory, and metabolic effects. Oral health benefits unique among herbal supplements. Overall excellent safety profile.
How They Measured It
Systematic review of clinical trials
Frequently Asked Questions
Common questions about Triphala research
There are currently 10 peer-reviewed studies on Triphala (Triphala), involving 720 total participants. Research covers Digestive health, Antioxidant status, Anti-inflammatory and 2 more areas. The overall evidence strength is rated as Very Strong.
The evidence is currently rated as "Very Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (9 human studies), and reported outcomes.
Triphala has been researched for: Digestive health, Antioxidant status, Anti-inflammatory, Weight management, Oral health. Each area has its own body of evidence which you can explore in the study breakdowns above.
Yes, 9 out of 10 studies are human trials. Human trials carry more weight in our evidence scoring system.
Similar Supplements
Other supplements researched for similar health goals
